Ten Years of Ribavirin Treatment for Pneumovirus and Paramyxovirus Infections in Lung Transplant Recipients

A. E. de Zwart,A. Riezebos-Brilman,J. C. Alffenaar,E. R. van den Heuvel,W. van der Bij,C. T. Gan,H. A. Kerstjens,E. A. Verschuuren

The journal of heart and lung transplantation/The Journal of heart and lung transplantation（2020）

引用 0|浏览21

暂无评分

摘要

We conclude that ribavirin should be considered as treatment option to possibly prevent allograft dysfunction in LTR with severe RSV, hMPV or PIV infection. We found no reason to discontinue MMF during these infections.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要